Replies to post #369750 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

kfa670,

Your “feelings” are spot on with what the average investor would feel and probably has a right to feel based on how most companies are expected to be managed. This company on the other hand has had to walk through so many mine fields that they aren’t telling anyone, including investors/potential spies/early sellouts, anything that leads to a direct indisputable conclusion. They don’t want to give anyone directions on where to lay the next mine field and they don’t want to lose control by massive buying from their “enemies” from exhausted longs at depressed prices. Everything, all at once and indisputable. Like a missle shot out of a cannon. If you look at how the ASMs were arranged to be delayed towards ASCO over the last few years you might understand better what Linda has been doing even if we don’t like it. Best wishes.

[biosectinvestor]

All of these companies take longer. I realize you see it that way. From my own experience investing in such regulated and complicated companies, I just don’t see any reason it would likely be that at all given the myriad but hard to predict reasons that almost every announcement for every company where there are dependencies, usually slides to 2, 3, sometimes many times longer. And during a pandemic? Every company I am in there is a contingent accusing every microcap CEO of being a damn liar... and wanting their heads, particularly during this pandemic. Normally, it’s some wise guy. But during the pandemic, it is walls of traders who in many cases have never been big in investing in biotech and that one company is their big play, and they do not get how ANY company could take 5 or more years to get a product to market. Must be lies and scams... for those who know otherwise, you see how that starts to sound no?